{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T12:53:28Z","timestamp":1773406408761,"version":"3.50.1"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2004,3,1]],"date-time":"2004-03-01T00:00:00Z","timestamp":1078099200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Can J Public Health"],"published-print":{"date-parts":[[2004,3]]},"DOI":"10.1007\/bf03405775","type":"journal-article","created":{"date-parts":[[2019,9,12]],"date-time":"2019-09-12T16:49:42Z","timestamp":1568306982000},"page":"99-103","source":"Crossref","is-referenced-by-count":71,"title":["Self-perceived Health Among Canadian Opiate Users"],"prefix":"10.17269","volume":"95","author":[{"given":"Peggy E.","family":"Millson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laurel","family":"Challacombe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul J.","family":"Villeneuve","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benedikt","family":"Fischer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carol J.","family":"Strike","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ted","family":"Myers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ron","family":"Shore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shaun","family":"Hopkins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Raftis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary","family":"Pearson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2004,3,1]]},"reference":[{"issue":"5","key":"BF03405775_CR1","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/BF03404513","volume":"90","author":"B Fischer","year":"1999","unstructured":"Fischer B, Gliksman L, Rehm J, Daniel N, Medved W. Comparing opiate users in methadone treatment with untreated opiate users: Results of a follow-up study with a Toronto opiate user cohort. Can J Public Health 1999;90(5):299\u2013303.","journal-title":"Can J Public Health"},{"issue":"7","key":"BF03405775_CR2","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1046\/j.1360-0443.1998.9379914.x","volume":"93","author":"E Single","year":"1998","unstructured":"Single E, Robson L, Xie X, Rehm J. The economic costs of alcohol, tobacco and illicit drugs in Canada, 1992. Addiction 1998;93(7):991\u20131006.","journal-title":"Addiction"},{"issue":"4","key":"BF03405775_CR3","doi-asserted-by":"publisher","first-page":"321","DOI":"10.2165\/00019053-199610040-00002","volume":"10","author":"GE Ralston","year":"1996","unstructured":"Ralston GE, Wilson P. Methadone programs: The costs and benefits to society and the individual. Pharmacoeconomics 1996;10(4):321\u201326.","journal-title":"Pharmacoeconomics"},{"issue":"22","key":"BF03405775_CR4","doi-asserted-by":"publisher","first-page":"1936","DOI":"10.1001\/jama.280.22.1936","volume":"280","author":"Anonymous.","year":"1998","unstructured":"Anonymous. Effective medical treatment of opiate addiction. National Consensus Development Panel on Effective Medical Treatment of Opiate Addiction. JAMA 1998;280(22):1936\u201343.","journal-title":"JAMA"},{"issue":"9148","key":"BF03405775_CR5","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/S0140-6736(98)05356-2","volume":"353","author":"J Ward","year":"1999","unstructured":"Ward J, Hall W, Mattick RP. Role of maintenance treatment in opioid dependence. The Lancet 1999;353(9148):221\u201326.","journal-title":"The Lancet"},{"issue":"1","key":"BF03405775_CR6","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1111\/j.1360-0443.1996.tb03160.x","volume":"91","author":"CF Ryan","year":"1996","unstructured":"Ryan CF, White JM. Health status at entry to methadone maintenance treatment using the SF36 health survey questionnaire. Addiction 1996;91(1):39\u201346.","journal-title":"Addiction"},{"key":"BF03405775_CR7","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/S0899-3289(99)80142-4","volume":"10","author":"MD Stein","year":"1998","unstructured":"Stein MD, Mulvey KP, Plough A, Samet JH. The functioning and well being of persons who seek treatment for drug and alcohol use. J Substance Abuse 1998;10:75\u201384.","journal-title":"J Substance Abuse"},{"key":"BF03405775_CR8","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1023\/A:1008836922089","volume":"7","author":"EA Schlenk","year":"1998","unstructured":"Schlenk EA, Erlen JA, Jacob- Dunbar J, McDowell J, Engberg S, Sereika SM, et al. Health-related quality of life in chronic disorders: A comparison across studies using the MOS SF-36. Quality Life Res 1998;7:57\u201365.","journal-title":"Quality Life Res"},{"key":"BF03405775_CR9","volume-title":"Measuring Healthy Days","author":"Centers for Disease ControlPrevention.","year":"2000","unstructured":"Centers for Disease Control and Prevention. Measuring Healthy Days. Atlanta, GA: CDC, November 2000."},{"issue":"4","key":"BF03405775_CR10","doi-asserted-by":"publisher","first-page":"547","DOI":"10.2105\/AJPH.82.4.547","volume":"82","author":"C v d Hartgers","year":"1992","unstructured":"Hartgers C, van den Hoek A, Krijnen P, Coutinho RA. HIV prevalence and risk behaviour among injecting drug users who participate in \u2018Low-Threshold\u2019 methadone programs in Amsterdam. Am J Public Health 1992;82(4):547\u201351.","journal-title":"Am J Public Health"},{"issue":"4","key":"BF03405775_CR11","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/S0306-4603(98)00083-5","volume":"24","author":"EJ Ameijden van","year":"1999","unstructured":"van Ameijden EJ, Langendam MW, Coutinho RA. Dose-effect relationship between overdose mortality and prescribed methadone dosage in low-threshold maintenance programs. Addictive Behav 1999;24(4):559\u201363.","journal-title":"Addictive Behav"},{"issue":"1","key":"BF03405775_CR12","doi-asserted-by":"publisher","first-page":"63","DOI":"10.3109\/16066359509005223","volume":"3","author":"E Finch","year":"1995","unstructured":"Finch E, Groves I, Feinmann C, Farmer R. A low-threshold methadone stabilisation programme description and first stage evaluation. Addiction Res 1995;3(1):63\u201371.","journal-title":"Addiction Res"},{"key":"BF03405775_CR13","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1097\/00005650-199206000-00002","volume":"30","author":"JE Ware Jr","year":"1992","unstructured":"Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992;30:473\u201383.","journal-title":"Med Care"},{"key":"BF03405775_CR14","volume-title":"SF36 Health Survey: Manual and Interpretation Guide","author":"JE Ware","year":"2000","unstructured":"Ware JE, Snow KK, Kosinski M. SF36 Health Survey: Manual and Interpretation Guide. Lincoln, RI: QualityMetric Incorporated, 1993, 2000."},{"key":"BF03405775_CR15","volume-title":"SF36 Physical and Mental Health Summary Scales: A User\u2019s Manual","author":"JE Ware","year":"1994","unstructured":"Ware JE, Kosinski M, Keller SD. SF36 Physical and Mental Health Summary Scales: A User\u2019s Manual. Boston, MA: Health Assessment Lab, 1994."},{"issue":"3","key":"BF03405775_CR16","first-page":"265","volume":"163","author":"WM Hopman","year":"2000","unstructured":"Hopman WM, Towheed T, Anastassiades T, Tenenhouse A, Poliquin S, Berger C, et al. Canadian Normative Data for the SF36 Health Survey. CMAJ 2000;163(3):265\u201371.","journal-title":"CMAJ"},{"issue":"3","key":"BF03405775_CR17","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1097\/00005650-199303000-00006","volume":"31","author":"CA McHorney","year":"1993","unstructured":"McHorney CA, Ware JE Jr, Raczek AE. The MOS 36-Item Short-Form Health Survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs. Med Care 1993;31(3):247\u201363.","journal-title":"Med Care"},{"key":"BF03405775_CR18","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/s100670050155","volume":"19","author":"FN Birrell","year":"2000","unstructured":"Birrell FN, Hassell AB, Jones PW, Dawes PT. How does the Short Form 36 Health Questionnaire (SF36) in Rheumatoid Arthritis (RA) relate to RA Outcomes measures and SF-36 Population Values? A cross-sectional study. Clinical Rheumatology 2000;19:195\u201399.","journal-title":"Clinical Rheumatology"},{"issue":"11","key":"BF03405775_CR19","doi-asserted-by":"publisher","first-page":"3599","DOI":"10.1097\/00003246-200011000-00006","volume":"28","author":"DK Heyland","year":"2000","unstructured":"Heyland DK, Hopman W, Coo H, Tanmer J, McColl MA. Long-term health-related quality of life in survivors of sepsis. Short Form 36: A valid and reliable measure of health-related quality of life. Crit Care Med 2000;28(11):3599\u2013605.","journal-title":"Crit Care Med"},{"issue":"6","key":"BF03405775_CR20","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1200\/JCO.2001.19.6.1619","volume":"19","author":"J E- Madalinska","year":"2001","unstructured":"Madalinska JB, Essink- Bot ML, de Koing HJ, Wim J, van der Mass PJ, Schroder FH. Healthrelated quality of life effects of radical prostatectomy and primary radiotherapy for screen detected or clinically diagnosed localized prostate cancer. J Clin Oncology 2001;19(6):1619\u201328.","journal-title":"J Clin Oncology"},{"key":"BF03405775_CR21","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1023\/A:1008917016998","volume":"8","author":"MA Singer","year":"1999","unstructured":"Singer MA, Hopman WM, MacKenzie TA. Physical functioning and mental health in patients with chronic medical conditions. Q Life Res 1999;8:687\u201391.","journal-title":"Q Life Res"},{"issue":"2","key":"BF03405775_CR22","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1136\/jnnp.73.2.116","volume":"73","author":"S Wiebe","year":"2002","unstructured":"Wiebe S, Matijevic S, Eliasziw M, Derry PA. Clinically important change in quality of life in epilepsy. J Neurology, Neurosurgery, Psychiatry 2002;73(2):116\u201320.","journal-title":"J Neurology, Neurosurgery, Psychiatry"},{"key":"BF03405775_CR23","volume-title":"Modern Epidemiology","author":"KJ Rothman","year":"1986","unstructured":"Rothman KJ. Modern Epidemiology. Boston: Little Brown and Company, 1986."},{"key":"BF03405775_CR24","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1001\/archpsyc.1982.04290020027006","volume":"39","author":"BJ Rounsaville","year":"1982","unstructured":"Rounsaville BJ, Weissman MM, Kleber H, Wilber C. Heterogeneity of psychiatric diagnosis in treated opiate addicts. Arch Gen Psychiatry 1982;39:161\u201368.","journal-title":"Arch Gen Psychiatry"},{"issue":"5","key":"BF03405775_CR25","doi-asserted-by":"publisher","first-page":"485","DOI":"10.3109\/16066350009005592","volume":"8","author":"J Brands","year":"2000","unstructured":"Brands J, Brands B, Marsh D. The expansion of methadone prescribing in Ontario, 1996\u20131998. Addiction Res 2000;8(5):485\u201396.","journal-title":"Addiction Res"}],"container-title":["Canadian Journal of Public Health"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03405775.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF03405775\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03405775.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,13]],"date-time":"2019-09-13T12:49:41Z","timestamp":1568378981000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF03405775"}},"subtitle":["A Comparison to the General Population and to Other Chronic Disease Populations"],"short-title":[],"issued":{"date-parts":[[2004,3]]},"references-count":25,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2004,3]]}},"alternative-id":["BF03405775"],"URL":"https:\/\/doi.org\/10.1007\/bf03405775","relation":{},"ISSN":["0008-4263","1920-7476"],"issn-type":[{"value":"0008-4263","type":"print"},{"value":"1920-7476","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,3]]}}}